Colitis ulcerosa: vizsgálatok itt: Svájc
7 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Bern, Saint Ursen, Zurich
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00 - 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Basel, Bern, Sankt Gallen
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - 3. fázisTaking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Bern
- Életkor
- 16 év to 80 év
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184996 - 3. fázisTaking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Bern
- Életkor
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - 3. fázisTaking peopleA Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Bern, Lausanne, Zurich
- Életkor
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00 - 3. fázisTaking peopleA Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Where
- Bern, Lausanne, Zurich
- Életkor
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00 - No phaseTaking peopleA Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
- Where
- Bern
- Életkor
- 18 év and over
- People
- 50
- Run by
- Janssen-Cilag A.G., Switzerland
See details and how to joinNCT07532213